Cherington Charles 4
4 · Ernexa Therapeutics Inc. · Filed Jun 11, 2025
Insider Transaction Report
Form 4
Cherington Charles
10% Owner
Transactions
- Purchase
Common Stock
2025-06-09$0.10/sh+21,241,163$2,221,826→ 41,659,743 total
Footnotes (2)
- [F1]On June 9, 2025, pursuant to a private placement offering by the Issuer and following the receipt of stockholder approval, the reporting person acquired 21,241,163 shares of the Issuer's Common Stock.
- [F2]On June 2, 2025, the Issuer paid a dividend to all holders of record of its Series A Preferred Stock on such date of $0.05 per share of Series A Preferred Stock. Pursuant to the terms of the Series A Preferred Stock, the Issuer elected to pay the dividend in an equivalent amount of Common Stock. As a result, the Reporting Person received 16,978 shares of the Issuer's Common Stock.